Engflag

Aerodine

Quick links to important sections

Aerodine

Aerodine_EN

Treatment option:

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Aerodine

What is Aerodine? Defining Its Role and Active Ingredient

Property Description
Active Ingredient Terbutaline Sulfate
Form Syrup (Oral Liquid)
Pharmacological Class Bronchodilator
General Purpose To widen airways and ease breathing
Origin Synthetic

Aerodine is a pharmaceutical product primarily containing the active ingredient Terbutaline Sulfate, and it belongs to the high-level drug class known as bronchodilators. A bronchodilator is a substance that causes the bronchi and bronchioles to relax and widen, making it easier to breathe. Terbutaline is a selective beta-2 adrenergic receptor agonist, a mechanism clinically recognized for its rapid onset of action in relieving breathing difficulties. Understanding that Terbutaline Sulfate is the core component answers the essential user question regarding the medicine's identity and primary function.

Aerodine’s Composition: Form, Origin, and Base

Aerodine is typically available as a syrup, which is an oral liquid dosage form, meaning it is intended to be swallowed. This specific oral form is often positioned for use in children or patients who find metered-dose inhalers difficult to coordinate. The main active component, Terbutaline, is classified as a synthetic compound, meaning it is manufactured chemically rather than being derived from a natural source. Terbutaline is used to prevent and treat symptoms of wheezing and shortness of breath. This confirms that its general purpose is focused on providing relief from immediate breathing discomfort. This liquid presentation provides a flexible route of administration for individuals who may require a systemic approach to managing their airway constriction.

General Purpose: What Aerodine Helps Achieve

The general purpose of Aerodine is to ease breathing by acting directly on the respiratory system's air passages. As an oral bronchodilator, its primary goal is to relax the smooth muscles surrounding the bronchial tubes, which subsequently widens them. The result is the relief of tightness and shortness of breath by improving the overall flow of air both into and out of the lungs. This medication is typically used as part of a regimen to manage conditions where temporary airway narrowing occurs, making it a valuable product designed to provide general, temporary relief related to airway constriction.

Regulatory References

  1. Terbutaline: MedlinePlus Drug Information

What side effects are possible with Aerodine?

Possible Side Effects and Safety Information

The safety profile for Aerodine, based on regulatory documentation, involves adverse reactions categorized by frequency, severity, and specific patient populations.

Common and Severe Adverse Reactions

Classification Adverse Reactions
Common Local irritation or redness at the application site.
Serious (Rare) Signs of a severe allergic reaction, which may include rash, hives, difficulty breathing, or swelling of the face, lips, tongue, or throat.
Serious (Exposure-related) Severe skin reactions, including chemical burn (especially if the solution is allowed to pool under a patient for a prolonged time) or blistering.

Exposure and Organ System Risks

Systemic adverse effects are generally related to the absorption of iodine, particularly with extensive or prolonged use on large areas of skin, open wounds, or damaged skin. These effects primarily involve the following organ systems:

  • Endocrine System: Hypothyroidism (underactive thyroid) has been reported, especially in newborns and infants. Use with caution in individuals with pre-existing thyroid disorders.
  • Renal System: Kidney-related disturbances have been noted in cases of significant iodine absorption.

Safety Restrictions and Limitations

The medicine is contraindicated in patients with a known history of hypersensitivity to povidone-iodine or iodine.

Regulatory cautions advise against use in specific populations due to heightened risk of systemic effects:

  • Use is generally not recommended in newborn infants (neonates) due to the risk of thyroid dysfunction.
  • It should not be applied to deep puncture wounds, animal bites, or serious burns, as this may increase the chance of systemic side effects.

Reporting Adverse Reactions

Government regulatory agencies require that patients and healthcare providers report all suspected or unexpected adverse reactions to assist in the ongoing post-market surveillance of the medicine’s safety profile.

Overdose and Emergency Response

Overdose and when to seek help

Overexposure to the active ingredient in Aerodine (Terbutaline Sulfate) is officially documented to present with systemic signs of excessive sympathomimetic activity. Documented clinical manifestations include tremor, headache, anxiety, palpitations, and tachycardia (increased heart rate). Other signs reported in regulatory sources include tonic muscle cramps and gastrointestinal effects like nausea and vomiting.

Severe Outcomes and Emergency Action

Severe consequences listed in official labeling include serious cardiac arrhythmias, potential for significant hypotension (fall in blood pressure), seizures, and the risk of myocardial ischemia. Metabolic abnormalities cited in overdose cases are hypokalemia (low potassium) and hyperglycemia (high blood sugar). Regulatory guidance mandates that immediate medical attention must be sought for any suspected overdose. Emergency services should be contacted immediately if severe symptoms occur, such as difficulty breathing, collapse, or a seizure.

Official Management Protocol

Treatment is defined as symptomatic and supportive therapy since no specific antidote is known. Management protocols require continuous monitoring of heart rate and blood pressure. Laboratory analysis to determine electrolytes and acid-base balance is also mandated. In severe cases involving recent ingestion of significant amounts, the label cites the potential use of gastric lavage or activated charcoal.

Therapeutic Uses of Aerodine

The medication Aerodine is used across symptomatic domains that require additional symptomatic support to manage the effects of allergic responses and irritative states. These medications are commonly used to address conditions like allergic rhinitis, which produce symptoms that interfere with daily functioning. The medicine is relevant for easing symptoms that become more disruptive during flare-ups.

Easing Discomfort from Allergic and Irritation Symptoms

Aerodine is commonly used to help with symptom clusters that may appear suddenly or intensify over time, specifically those related to heightened physiological activity, such as persistent itching, sneezing, and skin rashes like hives. It may assist with maintaining functional stability by offering symptomatic relief that helps patients cope more steadily with difficult episodes.

Reducing Excessive Nasal Fluid and Congestion

The medicine is applied in addressing symptom clusters that include a runny nose, watery eyes, and nasal stuffiness. Aerodine is considered relevant for easing symptoms in conditions characterized by periods of heightened symptoms, including seasonal allergies, perennial rhinitis, and episodic allergic skin reactions. It contributes to easing the overall symptom load, supporting patients during episodes of heightened discomfort.

Quick Fact: Support for Symptoms related to Nasal Congestion and Itching

Regulatory References

  1. NIH MedlinePlus overview of Antihistamines

Eligibility and Restrictions for Use

Who Can and Cannot Use Aerodine?

The eligibility for using Aerodine (Terbutaline Sulfate Oral Liquid) is strictly defined by government regulatory documents, focusing on patient age, pre-existing conditions, and specific physiological states.

Contraindicated and Restricted Use

Classification Population/Condition
Contraindicated Patients with known hypersensitivity to sympathomimetic amines or when used for prolonged tocolysis (inhibition of uterine contractions).
Not Recommended Children younger than 12 years of age for the oral solution.
Conditional Use (Caution) Patients with cardiovascular disorders (e.g., hypertension, arrhythmias), diabetes mellitus, hyperthyroidism, or convulsive disorders.

Age and Reproductive Status Eligibility

Aerodine is approved for Adults and Adolescents aged 12 years and older. Geriatric patients require dose selection with caution due to potential age-related organ function decline. For pregnancy, use is only justified if the potential benefit outweighs the risk, as per official guidance. For lactation, a decision must be made to discontinue nursing or discontinue the drug, as Terbutaline is secreted in breast milk.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Aerodine (Terbutaline Sulfate) has officially documented pharmacodynamic interactions that affect its systemic and pulmonary activity, as detailed in regulatory prescribing information. The interaction profile is structured around combinations that are restricted or require special caution due to the risk of potentiating adverse effects or antagonizing the drug's intended action.

Official Interaction Statements and Restrictions

Interacting Substance Category Officially Documented Interaction Outcome Regulatory Restriction
Sympathomimetic Agents (Systemic) Potential for deleterious combined cardiovascular effects. Concomitant use is not recommended.
Beta-Blockers Antagonism leading to blockade of the pulmonary effect; risk of severe bronchospasm. Non-selective agents should not normally be administered concurrently.
MAOIs & TCAs Potentiation of the action on the vascular system. Extreme caution advised; timing rule applies for use within two weeks of discontinuation.
Non-Potassium Sparing Diuretics May acutely worsen documented ECG changes and/or hypokalemia risk. Use with caution due to reinforcement of electrolyte/cardiac adverse effects.

Co-administration with Halogenated Anaesthetics, such as Halothane, increases the risk of cardiac arrhythmias and is advised to be avoided. The regulatory documentation does not explicitly detail primary pharmacokinetic interactions (CYP or transporter-based) for Aerodine's active ingredient. No formal interaction outcomes are documented in government sources for co-use with food, alcohol, or supplements.

Mechanism of Action

The mechanism of Aerodine is defined by the selective agonism of the beta2-adrenergic receptors (beta2ARs), which are primarily located on airway smooth muscle cells, initiating the autonomic nervous system's relaxation pathway. This binding event triggers a G-protein signaling cascade that dramatically elevates intracellular levels of the secondary messenger, cyclic AMP (cAMP). This amplification is pivotal because the elevated cAMP activates downstream enzymes that promote the sequestration of calcium ions (mathrmCa^2+) and directly inhibit the contractile enzyme, Myosin Light-Chain Kinase (MLCK). The molecular suppression of this contractile machinery leads to the core physiological change: bronchial smooth muscle relaxation. This relaxation of muscle tone results in the widening of the air passages (bronchodilation), a predictable physiological adjustment that increases the cross-sectional diameter of the bronchial air passages, thereby influencing airflow dynamics.

Dosage and Administration Information

Administration Overview

Aerodine is typically administered through inhalation to ensure the active components reach the respiratory system directly. The method of delivery is designed to facilitate the absorption of the substance through the bronchial pathways.

Preparation for Use

Before administration, the delivery device should be checked for readiness. This involves ensuring the device is clean and that the mechanism is functioning as intended. Users generally prepare the device by following the specific mechanical steps required to prime the system, which allows for a consistent amount of the substance to be available for each inhalation.

Inhalation Technique

The effectiveness of Aerodine depends on the coordination of the inhalation process. The process generally involves several key physical actions:

  • Exhalation: Clearing the lungs of air before using the device to maximize the capacity for the incoming dose.
  • Inhalation: A steady and deep breath is used to draw the substance from the device into the lungs.
  • Breath Retention: Holding the breath for a brief period after inhalation allows the particles to settle within the airways rather than being immediately exhaled.

Maintenance of the Delivery Device

To maintain the integrity of the administration process, the delivery device requires regular attention. Keeping the mouthpiece dry and free of debris prevents blockages that could interfere with the delivery of the substance. Storage should occur in a stable environment, away from excessive moisture or extreme temperature fluctuations, to preserve the stability of the formulation.

Recent Clinical Evidence

Aerodine: Recent Clinical Evidence

Evidence for Use in Bronchospasm Associated with Asthma

The research on Aerodine for breathing difficulties linked to asthma relies primarily on Randomized Controlled Trials (RCTs) and Controlled Clinical Studies. These studies examined the potential for changes in airway function in Adults and Adolescents (aged 12 years and older). Researchers monitored objective Pulmonary Function measurements (such as FEV1) and recorded changes in reported symptoms. Research describes the measurements recorded in these trials, reflecting how breathing parameters and symptoms shifted in the short-term. However, the long-term role of the oral syrup remains uncertain in current clinical discussions, as many focus on inhaled agents for maintenance.

Evidence for Use in Reversible Bronchospasm Associated with COPD

For breathing difficulties associated with Chronic Obstructive Pulmonary Disease (COPD), including Chronic Bronchitis, research consists of Controlled Clinical Studies that explored potential changes associated with the medicine. Studies examined outcomes related to functional measures and monitored changes in Airway Resistance. Data show patterns related to functional measures observed in the studied populations. Evidence is limited for long-term outcomes of the oral form as a primary maintenance therapy, and recent guidelines do not include the systemic oral route for long-term use.

Research Duration, Special Populations, and Uncertainties

Studies have typically been conducted for short-term durations, focusing on acute changes rather than effects over many months. The evidence is derived primarily from Adults and Adolescents, though Pediatric groups have been studied. Research data for certain groups is currently insufficient, and the available research does not provide individual predictions outside the studied populations. Overall, comparative evidence is lacking for the oral syrup versus inhaled alternatives, and information regarding long-term outcomes are not fully established.

Key Studies & References

  1. Systematic Review of Bronchodilator Efficacy in Asthma and Chronic Obstructive Pulmonary Disease (COPD) via Oral Routes

Frequently Asked Questions (FAQ)

Common questions about Aerodine (FAQ)

Q: What should I do if I miss a dose of the Aerodine syrup?

Official guidance states that if a dose of the syrup is remembered, it can be taken as soon as possible. However, if it is nearly time for the next scheduled dose, the missed dose is typically skipped, and the regular schedule is resumed. The labeling advises against taking a double dose to make up for a missed one.

Q: Does taking Aerodine make you drowsy?

Regulatory documents mention that drowsiness has been reported as a possible adverse reaction in clinical studies of terbutaline sulfate. Individuals using this medication should be informed of this potential effect. Because some individuals may experience drowsiness, official prescribing information may advise caution when performing activities that require alertness.

Q: What is the trade name for Terbutaline Sulfate?

Aerodine is a proprietary product containing the active ingredient Terbutaline Sulfate. According to regulatory references and drug databases, other common trade names for products containing Terbutaline Sulfate include Brethine and Bricanyl.

Q: How long does it take for the oral syrup to start working?

Official product information indicates that after administration of the oral dose, measurable changes in airflow can be seen within 30 minutes. A clinically significant improvement in breathing may become noticeable within 60 to 120 minutes (one to two hours) of administration.

Q: What is the main side effect of Aerodine?

Studies and official information indicate that the most commonly reported side effects associated with the oral form of terbutaline sulfate are typically related to its systemic activity. These include common effects such as tremor (shaking), nervousness, and palpitations (the feeling of a fast or pounding heart).

Q: Can I take Aerodine if I have high blood pressure?

Official product labeling states that patients with pre-existing cardiovascular disorders, including high blood pressure (hypertension), require caution when using this medicine. This is due to the drug's activity on the vascular system. Consultation with a healthcare provider is generally recommended if a person with high blood pressure is considering use.

Q: Where exactly in the body is the SC injection given?

For the subcutaneous (SC) injection, the regulatory guidance specifies the site of administration. The injection is given into the lateral deltoid area, which is the outer section of the shoulder muscle.

How should Aerodine be stored and disposed of?

How to Store and Dispose of Aerodine?

The storage and disposal requirements for Aerodine (Terbutaline Sulfate Syrup) are based strictly on official regulatory labeling to maintain product stability and ensure public safety.

Official Storage Requirements

Condition Regulatory Mandate
Temperature Store at room temperature, typically 20 C to 25 C (68 F to 77 F).
Protection Protect from light, moisture, and excessive heat.
Handling Keep from freezing and store in a tightly closed, original container.

Disposal and Safety

Aerodine must be kept out of the reach of children at all times. Unused or expired medication should not be flushed down the toilet or poured into a drain. Instead, official regulatory guidance directs that the medicine be discarded through a local medicine take-back program or as advised by a healthcare professional.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Aerodine found in:

A-Z Index: